SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001824293-22-000080
Filing Date
2022-11-03
Accepted
2022-11-03 16:34:30
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001824293-20220930.htm   iXBRL 10-Q 864684
2 EX-31.1 ex311_ceo302cert93022.htm EX-31.1 11084
3 EX-31.2 ex312_cfo302cert93022.htm EX-31.2 11082
4 EX-32.1 ex321_ceosection906cert930.htm EX-32.1 5796
5 EX-32.2 ex322_cfosection906cert930.htm EX-32.2 5781
11 GRAPHIC ck0001824293-20220930_g1.jpg GRAPHIC 95792
  Complete submission text file 0001824293-22-000080.txt   4403999

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001824293-20220930.xsd EX-101.SCH 28776
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001824293-20220930_cal.xml EX-101.CAL 41212
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001824293-20220930_def.xml EX-101.DEF 113137
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001824293-20220930_lab.xml EX-101.LAB 379125
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001824293-20220930_pre.xml EX-101.PRE 258628
53 EXTRACTED XBRL INSTANCE DOCUMENT ck0001824293-20220930_htm.xml XML 585313
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40034 | Film No.: 221358612
SIC: 2834 Pharmaceutical Preparations